Stockrabit · Analysts
Questions across 2 calls

Chetan Doshi

Tulsi Capital

Natco Pharma Limited

Natco Pharma Limited CC-Mar25.pdf · 2025-05-29
See, what I have been observing is you are very conservative in giving the forecasting about the overall business and you always exceed, whatever you say so, you exceed in the end of the year. That is my observation. So anyway, congratulations. Even 30% dr op on current profit, that is close to financial year '24, that much profit we do. So, don't you think you need to be a little bit liberal on distribution of the profits to the shareholders? And second question is what is the size of acquisition you are looking forward to which we intend to close in this financial year?
Sorry to interrupt. I think one of your ideas, you can surpass your current year profits also. One of the ideas it goes on floor, then it is a big boost to NATCO. That is for sure.

RHI MAGNESITA INDIA LIMITED

RHI MAGNESITA INDIA LIMITED CC-Mar24.pdf · 2024-05-29
Parmod, congratulations for the excellent set of numbers in the last quarter and delivering the results as per the expectations. Now just saw the investor presentation and immediately this Con Call is there. So, it is difficult to even analyze, because this is quite a detailed presentation made after a long time. Now, one or two questions are there. This last quarter, how you foresee for the current year that this growth what we have shown can be maintained in the current year? And second question is that profit before tax for standalone, when it is a combined entity, PBT has gone down. So how come that the acquired units, you are not making profit still?
Sorry to interrupt, but first slide, you have received lot of awards. So that shows the skill and the interest taken by the company to take care of the customers and feel the presence made to them.